What did @balancemyhormones actually say?
George Touliatos MD made a point that actually needed to be made: testosterone replacement therapy is not a universal fix. He said directly that TRT "is not the solution to all your health problems" and acknowledged that even men with documented testosterone deficiency may have other issues driving their symptoms. He also distinguished between TRT as a replacement protocol versus a performance cycle, which is a meaningful clinical distinction that gets blurred constantly in this corner of social media.
The context here matters. He used heart failure as his example of a condition where adding testosterone won't save someone who is critically ill. That is a fair, if clunkily delivered, point. He was pushing back against what he called the "sexiness" around TRT, where men assume low energy, poor mood, or reduced libido automatically means low T, and that fixing T fixes everything. Credit where it is due: that's a responsible message from someone operating in a space that frequently oversells the hormone.
Does the science back this up?
Yes, with important nuances. Testosterone deficiency (hypogonadism) is associated with fatigue, reduced muscle mass, depression, sexual dysfunction, and metabolic problems. Treating confirmed deficiency can improve those outcomes. But the word "confirmed" is doing a lot of work in that sentence, and the evidence is more complicated than TRT content creators typically admit.
The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) followed over 5,000 men with hypogonadism and found TRT did not significantly increase major cardiovascular events compared to placebo. That's reassuring news on cardiovascular safety. But the same trial was not designed to show TRT fixed everything, and the men who benefited most were those with clinically confirmed low T, not men chasing optimization from normal-low baseline levels.
On the heart failure point specifically, Touliatos is on solid ground. A 2019 meta-analysis by Caminiti et al. in the Journal of the American College of Cardiology found mixed results for testosterone in heart failure patients, with some benefit in selected stable patients but no signal that it reverses severe cardiac dysfunction. Giving testosterone to someone dying of heart failure is not a treatment strategy anyone is seriously proposing.
What did they get wrong (or right)?
Touliatos got the core message right: TRT is not a cure-all. He got the replacement-versus-cycle distinction right. These are real clinical concepts and he did not exaggerate their differences.
What he got muddled is the causation framing around heart failure. The line "it doesn't mean if you die with heart failure, taking the stressor we blame testosterone for this" is confusing in transcript form, but the underlying point appears to be that TRT should not be blamed for outcomes in patients who were already critically ill. That is defensible, but it also risks sliding into a different problem: using that framing to deflect legitimate concerns about inappropriate TRT use in cardiovascular patients.
He did not quantify what "deficiency" means, which is a real gap. There is genuine clinical debate about where to set the threshold. The American Urological Association defines symptomatic hypogonadism as total testosterone below 300 ng/dL with clinical symptoms. Many men receiving TRT in direct-to-consumer and telehealth settings do not meet that bar. That gap deserved mention.
What should you actually know?
TRT can produce real, meaningful benefits for men with confirmed hypogonadism. The operative word is confirmed, meaning blood tests plus clinical symptoms, not just feeling tired or wanting better gym results.
If your testosterone is genuinely low (below 300 ng/dL by AUA guidelines, with symptoms), therapy can improve energy, libido, body composition, and mood. Baillargeon et al. (2014, JAMA Internal Medicine) documented that TRT prescriptions tripled between 2001 and 2011 in the U.S., with a large portion going to men without documented deficiency. That trend has continued.
The multi-factorial point Touliatos made is the most practically useful thing in this clip. Sleep apnea, obesity, type 2 diabetes, thyroid dysfunction, and chronic stress all suppress testosterone independently. Treating the root cause often brings T levels back up without exogenous hormone. Getting on TRT before investigating those causes is putting the cart before the horse.
- Ask your provider for a morning total testosterone test on at least two separate days before any TRT conversation.
- Symptoms alone are not a diagnosis. The symptoms of low T overlap heavily with depression, sleep disorders, and metabolic disease.
- TRT suppresses your own testosterone production and affects fertility. That is not a temporary side effect, it persists during treatment.
- Heart failure is a real contraindication for TRT in many cases. Do not self-prescribe or use anecdotal protocols if you have cardiac conditions.